Physiomics develops mathematical models to predict the effect of therapeutic drugs. With an experienced team of dedicated scientists we work with our clients to answer their R&D questions and de-risk drug development.
“Working with Physiomics we were able to integrate multi-level preclinical data to build confidence in the clinical potential of our molecule. The Physiomics team leveraged their experience and knowledge to provide insightful conclusions on our project, working with great transparency, flexibility, and communication.”
Sylvain Fouliard, Head of Translational Pharmacometrics Servier
“Physiomics has provided PK/PD modelling and data analysis expertise on several of our oncology projects. We have found the group to be talented, experienced and committed to delivering high quality results in a timely manner. Physiomics has helped us achieve a more quantitative and translational understanding of our novel molecules.”
Phil Jeffrey, SVP Preclinical Development Bicycle Therapeutics
“We have worked with Physiomics on a PK/PD modelling project for our molecule NM26-2198, intended for use in patients with inflammatory disease. The work has been highly productive, valuable and enjoyable. The Physiomics team are knowledgeable, helpful and dedicated to provide the expertise required to bring the project to fruition. Based on this excellent collaboration we will certainly be working with Physiomics again.”
Daniel Snell, VP Translational Science
Numab Therapeutics AG
Interested in speaking with a consultant?
We’ll arrange a brief consultation for you with a specialist in our team.